Several genetic variants in IGF1 and IGFBP3 predicted circulating levels of IGF-I and IGFBP-3, respectively, but no associations between these variants and breast cancer, overall or in subgroups, were seen. This evidence concerns the gene IGFBP3 and breast carcinoma.